XML 26 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock, Series G-1 And G-2
Total Snowflake Inc. Stockholders’ Equity (Deficit)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interest
Beginning balance (in shares) at Jan. 31, 2020   169,921,000              
Beginning balance at Jan. 31, 2020   $ 936,474              
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of redeemable convertible preferred stock (in shares)     12,350,000            
Issuance of redeemable convertible preferred stock     $ 478,573            
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)   (182,271,000)              
Conversion of redeemable convertible preferred stock to common stock upon initial public offering   $ (1,415,047)              
Ending balance (in shares) at Jan. 31, 2021   0              
Ending balance at Jan. 31, 2021   $ 0              
Beginning balance (in shares) at Jan. 31, 2020 [1]         55,452,000        
Beginning balance at Jan. 31, 2020 $ (544,757)     $ (544,757) $ 6 [1] $ 155,340 $ 216 $ (700,319) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares) [1]         182,271,000        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 1,415,047     1,415,047 $ 18 [1] 1,415,029      
Issuance of common stock upon initial public offering and private placements, net of underwriting discounts (in shares) [1]         36,367,000        
Issuance of common stock upon initial public offering and private placements, net of underwriting discounts $ 4,242,284     4,242,284 $ 4 [1] 4,242,280      
Issuance of common stock upon exercise of stock options (in shares) 13,799,000       13,799,000 [1]        
Issuance of common stock upon exercise of stock options $ 53,671     53,671   53,671      
Exercise of common stock warrants (in shares) [1]         32,000        
Repurchase of early exercised stock options (in shares) [1]         (40,000)        
Vesting of early exercised stock options and restricted common stock 5,592     5,592   5,592      
Vesting of restricted stock units (in shares) [1]         37,000        
Stock-based compensation 303,513     303,513   303,513      
Other comprehensive income (loss) 223     223     223    
Net loss (539,102)     (539,102)       (539,102)  
Ending balance (in shares) at Jan. 31, 2021 [1]         287,918,000        
Ending balance at Jan. 31, 2021 $ 4,936,471     4,936,471 $ 28 [1] 6,175,425 439 (1,239,421) 0
Ending balance (in shares) at Jan. 31, 2022 0 0              
Ending balance at Jan. 31, 2022   $ 0              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) 20,903,000       20,903,000 [1]        
Issuance of common stock upon exercise of stock options $ 127,001     127,001 $ 3 [1] 126,998      
Issuance of common stock under employee stock purchase plan (in shares) [1]         370,000        
Issuance of common stock under employee stock purchase plan 52,227     52,227   52,227      
Vesting of early exercised stock options 750     750   750      
Vesting of restricted stock units (in shares) [1]         3,186,000        
Stock-based compensation 629,269     629,269   629,269      
Other comprehensive income (loss) (16,725)     (16,725)     (16,725)    
Net loss (679,948)     (679,948)       (679,948)  
Ending balance (in shares) at Jan. 31, 2022 [1]         312,377,000        
Ending balance at Jan. 31, 2022 $ 5,049,045     5,049,045 $ 31 [1] 6,984,669 (16,286) (1,919,369) 0
Ending balance (in shares) at Jan. 31, 2023 0 0              
Ending balance at Jan. 31, 2023   $ 0              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) 6,118,000       6,118,000 [1]        
Issuance of common stock upon exercise of stock options $ 39,743     39,743 $ 1 [1] 39,742      
Issuance of common stock under employee stock purchase plan (in shares) [1]         286,000        
Issuance of common stock under employee stock purchase plan 40,931     40,931   40,931      
Issuance of common stock in connection with a business combination (in shares) [1]         1,916,000        
Issuance of common stock in connection with a business combination 438,916     438,916   438,916      
Issuance of common stock in connection with a business combination subject to future vesting (in shares) [1]         409,000        
Vesting of early exercised stock options 244     244   244      
Vesting of restricted stock units (in shares) [1]         3,348,000        
Shares withheld related to net share settlement of equity awards (in shares) [1]         (1,149,000)        
Shares withheld related to net share settlement of equity awards (184,702)     (184,702)   (184,702)      
Stock-based compensation 890,950     890,950   890,950      
Capital contributions from noncontrolling interest holders 13,000               13,000
Other comprehensive income (loss) (21,986)     (21,986)     (21,986)    
Net loss (797,526)     (796,705)       (796,705) (821)
Ending balance (in shares) at Jan. 31, 2023 [1]         323,305,000        
Ending balance at Jan. 31, 2023 $ 5,468,615     $ 5,456,436 $ 32 [1] $ 8,210,750 $ (38,272) $ (2,716,074) $ 12,179
[1] On March 1, 2021, all shares of the Company’s then-outstanding Class B common stock were automatically converted into the same number of shares of Class A common stock, pursuant to the terms of the Company’s amended and restated certificate of incorporation. No additional shares of Class B common stock will be issued following such conversion. See Note 12 for further details.